No drug holidays in BRAFV600Eglioma patients: An argument for dose reduction of targeted therapies

MLA

Bazer, Danielle A., et al. “No Drug Holidays in BRAFV600Eglioma Patients: An Argument for Dose Reduction of Targeted Therapies.” Neuro-Oncology Practice, vol. 11, no. 5, Oct. 2024, pp. 660–64. EBSCOhost, https://doi.org/10.1093/nop/npae046.

APA

Bazer, D. A., Kolchinski, A., Bush, N. A. O., Clarke, J. L., Bagley, S. J., & Schreck, K. C. (2024). No drug holidays in BRAFV600Eglioma patients: An argument for dose reduction of targeted therapies. Neuro-Oncology Practice, 11(5), 660–664. https://doi.org/10.1093/nop/npae046

Chicago

Bazer, Danielle A, Anna Kolchinski, Nancy A O Bush, Jennifer L Clarke, Stephen J Bagley, and Karisa C Schreck. 2024. “No Drug Holidays in BRAFV600Eglioma Patients: An Argument for Dose Reduction of Targeted Therapies.” Neuro-Oncology Practice 11 (5): 660–64. doi:10.1093/nop/npae046.